Several advanced techniques have emerged to enhance drug screening for cancer:
3D Cell Cultures: Unlike 2D cultures, 3D cell cultures provide a more accurate representation of the tumor microenvironment, leading to better predictions of a drug’s effectiveness. Organoids: These are miniaturized and simplified versions of organs produced in vitro in three dimensions. They can mimic the complexity of human organs more accurately than traditional methods. CRISPR-Cas9 Screening: This genome-editing tool can be used to identify which genes are essential for cancer cell survival and how they interact with potential drugs. AI and Machine Learning: These technologies can analyze vast datasets to identify potential drug candidates more quickly and accurately than traditional methods.
